Since 1 January 2021, Intravacc is an independent public shareholding company, the State of the Netherlands being the sole shareholder. All members of Intravacc’s Supervisory Board have an outstanding track record at senior management level, both in the healthcare and pharmaceutical industries. Under the supervision of the Supervisory Board, Intravacc can further professionalise and develop into a full-fledged Contract Development & Manufacturing Organization.
For 20 years, Nico Oudendijk worked at the interface of Youth Care, Psychiatry and Crisis Care, 12 years of which as General Director of the Amsterdam psycho-social and psychiatric institute ‘Triangel’. Since 1991, Oudendijk has held various positions within the government within the Dutch Ministry of Health. These include director Mental Health Care and Professions, director of Curative Somatic Care, Director General Public Health, acting inspector-general at the Health Care Inspectorate (IGZ) and Envoy for the BES islands (The Caribbean Netherlands). From 2010 to 2012, he was director of the Netherlands Vaccine Institute (NVI), where he oversaw the sale its production facilities. From 2013 to 2020, he co-ordinated the preparations for the privatization of Intravacc.
Bruno Bruins is currently interim chairman of the board of HTM, the public transportation company of The Hague. From October 2017 to March 2020, Bruins was Minister for Medical Care and Sport at the Dutch Ministry of Health. Between 2012 and October 2017, Bruins was chairman of the board of Dutch National Employee Insurance Agency (UWV) and from 2008 to 2011 he was a member of the board of directors of public transportation company Connexxion Holding N.V. Bruins was State Secretary for Education, Culture and Science from July 2006 to February 2007 and from 2000 to 2006 he served as alderman of The Hague and, between 2004 and 2006, as deputy mayor. His side activities included the chairmanship of the Supervisory Board of the Dutch public broadcasting organization NPO (2016-2017).
Dr. Karin Dorrepaal is an experienced senior manager in the life science and pharmaceutical industry. In 1990 Dorrepaal joined Booz Allen Hamilton, Management Consultants. In 2004, the Supervisory Board of Schering AG appointed Dr. Dorrepaal as member of the Board of Management. After the takeover of Schering by Bayer, Dorrepaal left the company in 2006. Since then, she has held various board positions with private and listed companies in Germany, Ireland, Spain and the Netherlands.
Erik Popping joined Intravacc in January 2016. He has more than 14 years of experience within the pharmaceutical / healthcare industry as corporate and legal counsel. Before Erik joined Intravacc, he was Corporate & Legal counsel at the Hal Allergy Group. Prior to that he was the Legal Counsel of the Netherlands Vaccine Institute, a predecessor of Intravacc. He holds a Master’s degree in law (LL.M.) (Radboud University) and a Bachelor degree in business administration (HAN University of applied sciences).
Are you interested in becoming part of an innovative community, to learn alongside top scientists, to work with state-of-the art equipment, to get an inside look of and contribute to the biotech sector, where industry leaders, government, universities and international non-governmental organizations collaborate? Then Intravacc is the place for you.
Stay up to date with the latest developments, and be the first to receive our news updates and announcements.
